A new anti-viral drug could improve COVID-19 outcomes and survival rates—and is highly effective against multiple variants—according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke. The drug, called N-0385, blocks the SARS-CoV-2 virus from entering human cells through its favored cell gateways. The results of the
A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19, bringing “important hope” to sufferers, the lead researcher said Sunday. Jean-Claude Tardif, head of the Montreal Heart Institute (ICM), led the study named “Colcorona,” whose preliminary results were published Friday
A group of Canadian doctors are to begin prescribing trips to an art gallery to help patients suffering a range of ailments become a picture of health. A partnership between the Francophone Association of Doctors in Canada (MFdC) and the Montreal Museum of Fine Arts (MMFA) will allow patients suffering from a number of physical
Most Canadian smokers are in favour of novel policies to reduce tobacco use, according to a national survey by the International Tobacco Control Policy Evaluation Project (ITC) at the University of Waterloo. Responding to the Canadian government’s commitment to reduce tobacco use to less than five per cent of the population by 2035, the ITC
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok